Use of stereotactic body radiation therapy for oligometastatic recurrent prostate cancer: A systematic review-Reference-Cited by-同舟云学术

Use of stereotactic body radiation therapy for oligometastatic recurrent prostate cancer: A systematic review

Published:2018-05-28 Issue:5 Volume:62 Page:692-706
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:J Med Imaging Radiat Oncol

Author:

Vilela Ricardo Alencar¹²³^ORCID,Navarro Natássia Ferreira⁴,Faria Edison Tostes⁵,Ferreira Elaine Barros⁶,Ruzza Rachel Zomer²,Gadia Rafael⁷,Guerra Eliete Neves Silva⁶,Reis Paula Elaine Diniz dos⁶

Affiliation:

1. Grupo CONFIAR; Goiânia Brazil

2. Departamento de Rádio-oncologia; Instituto Nacional de Câncer; Rio de Janeiro Brazil

3. Departamento de Rádio-oncologia; Universidade Federal do Rio de Janeiro; Rio de Janeiro Brazil

4. Departamento de Medicina Interna; Hospital Regional da Asa Norte; Brasilia Brazil

5. Faculdade de Medicina; Universidade de Brasília; Brasilia Brazil

6. Faculdade de Ciências da Saúde; Universidade de Brasília; Brasilia Brazil

7. Departamento de Rádio-oncologia; Hospital Sírio Libanês; Brasilia Brazil

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1754-9485.12747/fullpdf

Reference45 articles.

1. Oligometastases;Hellman;J Clin Oncol,1995

2. Oligometastases revisited;Weichselbaum;Nat Rev Clin Oncol,2011

3. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer;Wolff;Eur J Cancer,2015

4. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer;Heidenreich;Eur Urol,2014

5. Management options for biochemically recurrent prostate cancer;Fakhrejahani;Curr Treat Options Oncol,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort;Clinical Lung Cancer;2023-11

2. The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives;Critical Reviews in Oncology/Hematology;2023-06

3. Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions;Therapeutic Advances in Medical Oncology;2023-01

4. Oligometastatic Prostate Cancer: Current Status and Future Challenges;Journal of Nuclear Medicine;2022-11

5. Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management;Progrès en Urologie;2022-06